PFIZER INC
PFECIK 0000078003 · Pharmaceutical Preparations · NYSE
- PFIZER INC (until 2026-06-18)
Revenue (TTM)
$100.08B
−44.5% YoY
Q1 Apr 2026
Net Income (TTM)
$12.11B
−3.2% YoY
Q1 Apr 2026
EPS Diluted (TTM)
$2.12
−3.5% YoY
Q1 Apr 2026
Gross Margin
85.7%
Q1 Apr 2026
Operating Margin
—
Q1 Apr 2026
Net Margin
12.1%
Q1 Apr 2026
Free Cash Flow (TTM)
$4.41B
Q1 Apr 2026
Cash
$1.7B
Q1 Apr 2026
Total Debt
$64.46B
Q1 Apr 2026
Shares Outstanding
5.7B sh
Q1 Apr 2026
Revenue & Net Income
EPS (Diluted)
Margins
Cash Flow
Revenue Growth (YoY)
Balance Sheet
Cash vs Debt
Latest news
All news →-
Moderate Neutral
Pfizer CFO Dave Denton to Step Down in August
Interim Chief Financial Officer Cecile Guegan takes over as Pfizer launches search for permanent replacement.